Thermo Fisher to make COVID-19 RT-PCR testing kits in Bengaluru Coronavirus in India: The new facility will have a capacity to manufacture up to 10 million tests every month. CoviPath COVID-19 RT-PCR Kit has been approved by the ICMR and DCGI PB Jayakumar | February 17, 2021 | Updated 10:14 IST Thermo Fisher to make coronavirus test kits in India Thermo Fisher Scientific, one of the leading global medical devices manufacturers, will produce COVID-19 testing kits and diagnostic solutions at its manufacturing facility in Bengaluru for the Indian market. The new facility will have a capacity to manufacture up to 10 million tests every month. "This facility will be instrumental in ensuring access to affordable testing kits while maintaining global quality standards," said Amit Chopra, managing director, India and South Asia, Thermo Fisher Scientific.